Suscribirse

Reducing Prescribing Errors Through Creatinine Clearance Alert Redesign - 18/09/15

Doi : 10.1016/j.amjmed.2015.05.033 
Brittany L. Melton, PhD, PharmD a, ⁎ , Alan J. Zillich, PharmD b, c, d, e, Scott A. Russell, BSE, MS b, Michael Weiner, MD, MPH b, c, d, M. Sue McManus, PhD, NP f, Jeffrey R. Spina, MD g, h, Alissa L. Russ, PhD b, c, d, e
a School of Pharmacy, University of Kansas, Lawrence 
b Center for Health Information and Communication, Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development Service CIN 13-416, Indianapolis, Ind 
c Regenstrief Institute, Inc, Indianapolis, Ind 
d Indiana University Center for Health Services and Outcomes Research, Indianapolis 
e College of Pharmacy, Purdue University, West Lafayette, Ind 
f Department of Veterans Affairs, Nephrology Services Central Texas, Temple 
g VA Greater Los Angeles Healthcare System, Los Angeles, Calif 
h David Geffen School of Medicine, University of California, Los Angeles 

∗Requests for reprints should be addressed to Brittany L. Melton, PhD, PharmD, 3901 Rainbow Blvd, Wescoe 6012, Mailstop 4047, Kansas City, KS 66160.

Abstract

Background

Literature has shown that computerized creatinine clearance alerts reduce errors during prescribing, and applying human factors principles may further reduce errors. Our objective was to apply human factors principles to creatinine clearance alert design and assess whether the redesigned alerts increase usability and reduce prescribing errors compared with the original alerts.

Methods

Twenty Veterans Affairs (VA) outpatient providers (14 physicians, 2 nurse practitioners, and 4 clinical pharmacists) completed 2 usability sessions in a counterbalanced study to evaluate original and redesigned alerts. Each session consisted of fictional patient scenarios with 3 medications that warranted prescribing changes because of renal impairment, each associated with creatinine clearance alerts. Quantitative and qualitative data were collected to assess alert usability and the occurrence of prescribing errors.

Results

There were 43% fewer prescribing errors with the redesigned alerts compared with the original alerts (P = .001). Compared with the original alerts, redesigned alerts significantly reduced prescribing errors for allopurinol and ibuprofen (85% vs 40% and 65% vs 25%, P = .012 and P = .008, respectively), but not for spironolactone (85% vs 65%). Nine providers (45%) voiced confusion about why the alert was appearing when they encountered the original alert design. When laboratory links were presented on the redesigned alert, laboratory information was accessed 3.5 times more frequently.

Conclusions

Although prescribing errors were high with both alert designs, the redesigned alerts significantly improved prescribing outcomes. This investigation provides some of the first evidence on how alerts may be designed to support safer prescribing for patients with renal impairment.

El texto completo de este artículo está disponible en PDF.

Keywords : Electronic health records, Evaluation, Health information technology, Patient safety, Renal disease


Esquema


 Funding: This work was supported by VA Health Services Research & Development Grant PPO 09-298 (Principal Investigator, ALR). AJZ and ALR were supported by VA Health Services Research & Development Research Career Development Awards (CDA 11-214, and RCD 06-304-1, respectively). The views expressed in this article are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs or the US government.
 Conflict of Interest: None.
 Authorship: All authors had access to the data and played a role in writing this manuscript.


© 2015  Elsevier Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 128 - N° 10

P. 1117-1125 - octobre 2015 Regresar al número
Artículo precedente Artículo precedente
  • ‘Chest Pain Typicality’ in Suspected Acute Coronary Syndromes and the Impact of Clinical Experience
  • Edward W. Carlton, Martin Than, Louise Cullen, Ahmed Khattab, Kim Greaves
| Artículo siguiente Artículo siguiente
  • A Meta-analysis of Sleep-promoting Interventions During Critical Illness
  • Chithra Poongkunran, Santosh G. John, Arun S. Kannan, Safal Shetty, Christian Bime, Sairam Parthasarathy

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.